KURA ONCOLOGY INC (KURA)

US50127T1097 - Common Stock

9.01  +0.04 (+0.45%)

After market: 9.1738 +0.16 (+1.82%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/A
106.66%
N/A
864.73%
N/A
63.40%
N/A
80.21%
N/A
63.86%
N/A
68.59%
N/A
-22.33%
EBITDA
YoY % growth
-1.93M-23.62M
-1,123.83%
-28.34M
-19.98%
-36.05M
-27.21%
-62.87M
-74.40%
-67.48M
-7.33%
-91.71M
-35.91%
-130.7M
-42.51%
-139.11M
-6.43%
-164.955M
-18.58%
N/A
-44.72%
N/A
-7.47%
N/A
-9.22%
N/A
-38.72%
N/A
51.12%
N/A
68.33%
N/AN/A
EBIT
YoY % growth
-1.93M-23.64M
-1,124.87%
-28.37M
-20.01%
-36.08M
-27.18%
-62.88M
-74.28%
-67.48M
-7.32%
-91.9M
-36.19%
-131.26M
-42.83%
-139.87M
-6.56%
-165.804M
-18.54%
N/A
-39.33%
N/A
0.98%
N/A
15.89%
N/A
30.93%
N/A
76.90%
N/A
832.71%
N/A
160.05%
N/A
-19.09%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/A-1.47
44.14%
-1.54
-4.76%
-1.73
-12.34%
-1.50
13.29%
-1.69
-12.67%
-1.96
-15.98%
-2.03
-3.57%
-2.08
-2.46%
N/A
-1.50%
N/A
-10.60%
N/A
2.02%
N/A
41.67%
N/A
87.14%
N/A
1,508.20%
N/A
175.44%
N/A
-35.25%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.39
28.27%
-0.71
-20.28%
-0.74
-24.97%
-0.77
-22.12%
-0.58
-48.11%
Revenue
Q2Q % growth
30.388M14.28M
-53.01%
EBITDA
Q2Q % growth
-63.281M
-37.83%
-66.137M
-21.98%
-67.463M
-20.54%
-68.809M
-16.15%
-43.646M
31.03%
EBIT
Q2Q % growth
-59.256M
-26.72%
-64.507M
-18.47%
-40.537M
28.13%
-69M
-15.22%
-37.031M
37.51%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.63
-26.00%
-0.640.011.27%
Q2 2024
Q2Q % growth
-0.59
-11.32%
-0.640.058.05%
Q1 2024
Q2Q % growth
-0.59
-18.00%
-0.56-0.03-5.24%
Q4 2023
Q2Q % growth
-0.55
-12.24%
-0.560.011.83%
Q3 2023
Q2Q % growth
-0.50
5.66%
-0.560.0610.79%
Q2 2023
Q2Q % growth
-0.53
-1.92%
-0.560.035.51%
Q1 2023
Q2Q % growth
-0.50
-2.04%
-0.550.059.87%
Q4 2022
Q2Q % growth
-0.49 -0.580.0916.02%
Q3 2022
Q2Q % growth
-0.53
-6.00%
-0.570.047.54%
Q2 2022
Q2Q % growth
-0.52
-1.96%
-0.530.011.12%
Q1 2022
Q2Q % growth
-0.49
-6.52%
-0.530.047.03%
Q4 2021
Q2Q % growth
-0.49
-8.89%
-0.540.059.36%
Q3 2021
Q2Q % growth
-0.50
-19.05%
-0.550.058.89%
Q2 2021
Q2Q % growth
-0.51
-27.50%
-0.50-0.01-2.40%
Q1 2021
Q2Q % growth
-0.46
-9.52%
-0.43-0.03-7.80%
Q4 2020
Q2Q % growth
-0.45
-15.38%
-0.460.012.59%
Q3 2020
Q2Q % growth
-0.42
-16.67%
-0.40-0.02-3.88%
Q2 2020
Q2Q % growth
-0.40
-5.26%
-0.430.037.32%
Q1 2020
Q2Q % growth
-0.42
-13.51%
-0.430.011.96%
Q4 2019
Q2Q % growth
-0.39
7.14%
-0.420.037.70%
Q3 2019
Q2Q % growth
-0.36
10.00%
-0.400.049.71%
Q2 2019
Q2Q % growth
-0.38
15.56%
-0.420.049.55%
Q1 2019
Q2Q % growth
-0.37
19.57%
-0.450.0818.33%
Q4 2018
Q2Q % growth
-0.42 -0.430.011.26%
Q3 2018
Q2Q % growth
-0.40 -0.440.048.22%
Q2 2018
Q2Q % growth
-0.45 -0.460.011.27%
Q1 2018
Q2Q % growth
-0.46 -0.35-0.11-29.90%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2020
Q2Q % growth
51K-51K-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS37.91% 42.93% 15.42% 15.04%
Revenue1091.69% N/A N/A N/A